Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

被引：0
|
作者：
Huaiyu Yang
Lara Sinicropi-Yao
Sarah Chuzi
Soo Jeong Youn
Alisabet Clain
Lee Baer
Ying Chen
Patrick J McGrath
Maurizio Fava
George I Papakostas
机构：
[1] Harvard Medical School,Depression Clinical and Research Program, Massachusetts General Hospital
[2] Columbia University,Depression Evaluation Service Center, New York State Psychiatric Institute
来源：
Annals of General Psychiatry | / 9卷
关键词：
Major Depressive Disorder; Fluoxetine; Major Depressive Disorder; Hamilton Depression Rate Scale; Residual Symptom;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Modafinil combined with selective serotonin reuptake inhibitor at treatment initiation enhances the rate and degree of benefit in major depressive disorder
    Hassman, HA
    Glass, SJ
    Sciamanna, A
    Ninan, PT
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S197 - S197
  • [32] FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder
    Ellsworth, Katarzyna A.
    Moon, Irene
    Eckloff, Bruce W.
    Fridley, Brooke L.
    Jenkins, Gregory D.
    Batzler, Anthony
    Biernacka, Joanna M.
    Abo, Ryan
    Brisbin, Abra
    Ji, Yuan
    Hebbring, Scott
    Wieben, Eric D.
    Mrazek, David A.
    Weinshilboum, Richard M.
    Wang, Liewei
    PHARMACOGENETICS AND GENOMICS, 2013, 23 (03): : 156 - 166
  • [33] Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics
    Ji, Y.
    Biernacka, J. M.
    Hebbring, S.
    Chai, Y.
    Jenkins, G. D.
    Batzler, A.
    Snyder, K. A.
    Drews, M. S.
    Desta, Z.
    Flockhart, D.
    Mushiroda, T.
    Kubo, M.
    Nakamura, Y.
    Kamatani, N.
    Schaid, D.
    Weinshilboum, R. M.
    Mrazek, D. A.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (05): : 456 - 463
  • [34] A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder
    Papakostas, George I.
    Nelson, J. Craig
    Kasper, Siegfried
    Moeller, Hans-Juergen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (02) : 122 - 127
  • [35] Desvenlafaxine: A New Serotonin-Norepinephrine Reuptake Inhibitor for the Treatment of Adults With Major Depressive Disorder
    Perry, Richard
    Cassagnol, Manouchkathe
    CLINICAL THERAPEUTICS, 2009, 31 : 1374 - 1404
  • [36] LEVOMILNACIPRAN HYDROCHLORIDE Serotonin and Norepinephrine Reuptake Inhibitor Treatment of Major Depressive Disorder Treatment of Ischemic Stroke
    Haddley, K.
    DRUGS OF THE FUTURE, 2012, 37 (12) : 841 - 845
  • [37] The Relationship Between Adverse Events During Selective Serotonin Reuptake Inhibitor Treatment for Major Depressive Disorder and Nonremission in the Suicide Assessment Methodology Study
    Daly, Ella J.
    Trivedi, Madhukar H.
    Fava, Maurizio
    Shelton, Richard
    Wisniewski, Stephen R.
    Morris, David W.
    Stegman, Diane
    Preskorn, Sheldon H.
    Rush, A. John
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (01) : 31 - 38
  • [38] Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder:: A systematic review
    Ruhe, Henricus G.
    Huyser, Jochanan
    Swinkels, Jan A.
    Schene, Aart H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (12) : 1836 - 1855
  • [39] SERTRALINE, A SELECTIVE INHIBITOR OF SEROTONIN UPTAKE, FOR THE TREATMENT OF OUTPATIENTS WITH MAJOR DEPRESSIVE DISORDER
    REIMHERR, FW
    BYERLEY, WF
    WARD, MF
    LEBEGUE, BJ
    WENDER, PH
    PSYCHOPHARMACOLOGY BULLETIN, 1988, 24 (01) : 200 - 205
  • [40] Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder
    Papakostas, GI
    Petersen, TJ
    Kinrys, G
    Burns, AM
    Worthington, JJ
    Alpert, JE
    Fava, M
    Nierenberg, AA
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (10) : 1326 - 1330
12345